The metabolic syndrome among patients with cardiovascular disease in Accra, Ghana

J Akpalu1, A Akpalu, F Ofei

  • 1Department of Medicine, Korle Bu Teaching Hospital, and Department of Medicine & Therapeutics, University of Ghana Medical School, PO Box KB 77, Korle Bu, Accra, Ghana. janduah@yahoo.com

Ghana Medical Journal
|February 24, 2012
PubMed

Insights

Metabolic Syndrome is common in Ghanaian cardiovascular disease patients, increasing their risk. Early screening and intervention for Metabolic Syndrome components are crucial for preventing cardiovascular disease in adults.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Public Health

Background:

  • Metabolic Syndrome is linked to increased cardiovascular disease (CVD) risk.
  • CVD, once rare in Africa, is now a significant public health issue.
  • Understanding Metabolic Syndrome prevalence in CVD patients in Ghana is vital.

Purpose of the Study:

  • To determine the frequency of Metabolic Syndrome in Ghanaian patients with CVD.
  • To assess the association between Metabolic Syndrome and CVD in this population.

Main Methods:

  • A case-control study involving 100 CVD patients and 100 controls at Korle Bu Teaching Hospital, Ghana.
  • Interviews, physical examinations, anthropometric measurements, and fasting blood samples were collected.
  • Diagnosis of Metabolic Syndrome used National Cholesterol Education Programme: Adult Treatment Panel III criteria.

Main Results:

  • Metabolic Syndrome prevalence was 54% in CVD patients versus 18% in controls.
  • Hypertension and central obesity were the most frequent components.
  • Metabolic Syndrome significantly increased CVD risk (OR=5.35), with risk escalating with more components.

Conclusions:

  • Metabolic Syndrome is highly prevalent among Ghanaian CVD patients.
  • A strong association exists between Metabolic Syndrome components and CVD development.
  • Routine screening and interventions for Metabolic Syndrome are recommended for Ghanaian adults.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...